The past, present, and future of antibiotics

MA Cook, GD Wright - Science translational medicine, 2022 - science.org
Antibiotics have transformed modern medicine. They are essential for treating infectious
diseases and enable vital therapies and procedures. However, despite this success, their …

Photocatalytic Self-Fenton System of gC3N4-Based for Degradation of Emerging Contaminants: A Review of Advances and Prospects

Z Chen, Y Yan, C Lu, X Lin, Z Fu, W Shi, F Guo - Molecules, 2023 - mdpi.com
The discharge of emerging pollutants in the industrial process poses a severe threat to the
ecological environment and human health. Photocatalytic self-Fenton technology combines …

Antiviral and bivalent vaccine efficacy against an omicron XBB. 1.5 isolate

R Uraki, M Ito, M Kiso, S Yamayoshi… - The Lancet Infectious …, 2023 - thelancet.com
As of January 2023, SARS-CoV-2 subvariants BQ. 1 (a BA. 5 subvariant) and XBB (a BA. 2
subvariant) have replaced previously dominant omicro n variants globally, including BA. 5 …

NDM-9 resistance to taniborbactam

C Le Terrier, V Gruenig, C Fournier… - The Lancet Infectious …, 2023 - thelancet.com
Acquired resistance to carbapenems in Gram-negative bacteria is mostly related to
acquisition of carbapenemhydrolysing β-lactamases, among which metallo-β-lactamases …

Selection of AmpC β-lactamase variants and metallo-β-lactamases leading to ceftolozane/tazobactam and ceftazidime/avibactam resistance during treatment of MDR …

A Ruedas-López, I Alonso-García… - Antimicrobial Agents …, 2022 - Am Soc Microbiol
Infections caused by ceftolozane-tazobactam and ceftazidime-avibactam-resistant P.
aeruginosa infections are an emerging concern. We aimed to analyze the underlying …

In vitro activity of cefiderocol against MBL-producing Gram-negative bacteria collected in North America and Europe in five consecutive annual multinational SIDERO …

M Takemura, MG Wise, MA Hackel… - Journal of …, 2023 - academic.oup.com
Objectives To evaluate the in vitro antibacterial activity of cefiderocol, a siderophore
cephalosporin against MBL-producing clinical isolates. Methods MBL-producing strains …

Metallo-β-lactamases and a tug-of-war for the available zinc at the host–pathogen interface

G Bahr, LJ González, AJ Vila - Current opinion in chemical biology, 2022 - Elsevier
Abstract Metallo-β-lactamases (MBLs) are zinc-dependent hydrolases that inactivate
virtually all β-lactam antibiotics. The expression of MBLs by Gram-negative bacteria severely …

Prevalence and clonal diversity of carbapenem-resistant Klebsiella pneumoniae causing neonatal infections: A systematic review of 128 articles across 30 countries

Y Hu, Y Yang, Y Feng, Q Fang, C Wang, F Zhao… - PLoS …, 2023 - journals.plos.org
Background Klebsiella pneumoniae is the most common pathogen causing neonatal
infections, leading to high mortality worldwide. Along with increasing antimicrobial use in …

[HTML][HTML] Recent development in the sustainable remediation of antibiotics: a review

KK Sodhi, CK Singh - Total Environment Research Themes, 2022 - Elsevier
Antibiotics are identified as an emerging contaminant due to their persistence in the
environment. Antibiotics, due to their accumulation in freshwater sources and wastewater …

Structural basis of metallo-β-lactamase resistance to taniborbactam

SI Drusin, C Le Terrier, L Poirel… - Antimicrobial Agents …, 2024 - Am Soc Microbiol
The design of inhibitors against metallo-β-lactamases (MBLs), the largest family of
carbapenemases, has been a strategic goal in designing novel antimicrobial therapies. In …